News
📈 Stocks
Novartis Shares Plunge 11% After $32 Billion Market Value Wipeout
(just now)
Novartis stock plummeted 10.9% following the failure of its del-desiran trial, triggering a sector-wide selloff in muscular-disease stocks including Sarepta and Dyne…